Literature DB >> 26845047

The Evaluation and Management of Tall Stature.

Sabine E Hannema1, Lars Sävendahl.   

Abstract

Tall stature is a common reason for consultation of a paediatric endocrinologist. It is important to always consider underlying pathology. We propose a diagnostic flowchart based on five questions. (1) Does the child have tall stature? (2) Is there evidence of a syndrome? (3) Has there been growth acceleration? (4) Are there signs of puberty? (5) Does the child grow within the target height range? Diagnostic tests can then be ordered targeted to the suspected disorder. The Bayley-Pinneau and Tanner-Whitehouse methods are reasonably accurate in predicting adult height based on bone age in girls, but neither method performs well in boys. Tall stature is not a pathological condition and generally does not need treatment. However, adolescents with a strong treatment wish and their parents should be counselled on the effectivity and safety of available treatments including surgery and high-dose sex steroids. Surgical epiphysiodesis has the advantage that a reasonable height reduction can be achieved at a more advanced bone age, allowing a more accurate adult height prediction to base any treatment decision on. We feel that high-dose oestrogen treatment should no longer be used because of its association with reduced fecundity and imminent ovarian failure.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26845047     DOI: 10.1159/000443685

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  7 in total

Review 1.  Tall stature: a difficult diagnosis?

Authors:  Cristina Meazza; Chiara Gertosio; Roberta Giacchero; Sara Pagani; Mauro Bozzola
Journal:  Ital J Pediatr       Date:  2017-08-03       Impact factor: 2.638

Review 2.  Tall Stature: A Challenge for Clinicians.

Authors:  Beatriz Corredor; Mehul Dattani; Chiara Gertosio; Mauro Bozzola
Journal:  Curr Pediatr Rev       Date:  2019

3.  Identifying underlying medical causes of pediatric obesity: Results of a systematic diagnostic approach in a pediatric obesity center.

Authors:  Lotte Kleinendorst; Ozair Abawi; Bibian van der Voorn; Mieke H T M Jongejan; Annelies E Brandsma; Jenny A Visser; Elisabeth F C van Rossum; Bert van der Zwaag; Mariëlle Alders; Elles M J Boon; Mieke M van Haelst; Erica L T van den Akker
Journal:  PLoS One       Date:  2020-05-08       Impact factor: 3.240

4.  Etiology and Clinical Profile of Patients with Tall Stature: A Single-Center Experience.

Authors:  Alpesh Goyal; Viveka P Jyotsna; Arun K C Singh; Yashdeep Gupta; Rajesh Khadgawat
Journal:  Indian J Endocrinol Metab       Date:  2020-11-09

5.  The aetiology of extreme tall stature in a screened Finnish paediatric population.

Authors:  Juho Kärkinen; Eero Sorakunnas; Päivi J Miettinen; Taneli Raivio; Matti Hero
Journal:  EClinicalMedicine       Date:  2021-11-20

6.  Anti-Müllerian hormone and letrozole levels in boys with constitutional delay of growth and puberty treated with letrozole or testosterone.

Authors:  E Kohva; T Varimo; H Huopio; S Tenhola; R Voutilainen; J Toppari; P J Miettinen; K Vaaralahti; J Viinamäki; J T Backman; M Hero; T Raivio
Journal:  Hum Reprod       Date:  2020-02-29       Impact factor: 6.918

7.  Case Report: Bilateral Epiphysiodesis Due to Extreme Tall Stature in a Girl With a De Novo DNMT3A Variant Associated With Tatton-Brown-Rahman Syndrome.

Authors:  Otto Lennartsson; Maria Lodefalk; Henrik Wehtje; Eva-Lena Stattin; Lars Sävendahl; Ola Nilsson
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-13       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.